Cingulate Inc. Common Stock (CING)
Cingulate Inc. is a biopharmaceutical company focused on developing therapies for neuropsychiatric and neurological disorders. It specializes in creating novel treatments targeting conditions such as depression, anxiety, and pain, leveraging its expertise in brain chemistry and drug delivery.
Company News
Cingulate Inc. placed CEO Shane J. Schaffer on administrative leave due to unrelated legal matters. Jennifer Callahan was appointed interim CEO, retaining her CFO role, while board member Jay Roberts became Executive Chairman to ensure business continuity.
WD-40 Company reported stronger-than-expected Q3 results, leading to a 12.5% jump in its stock price in pre-market trading. Several other stocks also saw significant price movements in the pre-market session.
Investors should consider this list of healthcare stocks for 2024
Short squeeze penny stocks to watch. The post Best Penny Stocks To Buy? 3 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.